Literature DB >> 10554022

The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.

D Maier1, G Jones, X Li, A H Schönthal, O Gratzl, E G Van Meir, A Merlo.   

Abstract

The tumor suppressor PTEN negatively controls the phosphoinositide 3-kinase pathway for cell survival by dephosphorylating the phospholipid substrates phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. PTEN has been proposed to dephosphorylate focal adhesion kinase and is implicated in the regulation of cell spreading and motility. We analyzed the role of PTEN in invasion using the two highly infiltrative glioma cell lines U87MG (which lacks functional PTEN) and LN229 (wild-type PTEN). After constitutive overexpression of wild-type and phosphatase-deficient (C124S) PTEN, we found significant inhibition of invasion (50-70%) independent of the PTEN status of the cell and of the catalytic core domain of PTEN. Although wild-type but not mutant (C124S) PTEN decreased PKB/Akt phosphorylation and induced a stellate morphology in U87MG cells, an accompanying reduction of focal adhesion kinase phosphorylation was not seen. We conclude that phosphatase-independent domains of PTEN markedly reduced the invasive potential of glioma cells, defining a structural role for PTEN that regulates cell motility distinct of the PKB/Akt pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554022

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  PTEN induces apoptosis and cavitation via HIF-2-dependent Bnip3 upregulation during epithelial lumen formation.

Authors:  Y Qi; J Liu; S Saadat; X Tian; Y Han; G-H Fong; P P Pandolfi; L Y Lee; S Li
Journal:  Cell Death Differ       Date:  2014-11-14       Impact factor: 15.828

2.  mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.

Authors:  Xiaoyi Hu; Pier Paolo Pandolfi; Yi Li; Jason A Koutcher; Marc Rosenblum; Eric C Holland
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

3.  PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.

Authors:  Stacey L Thomas; Ridwan Alam; Nancy Lemke; Lonni R Schultz; Jorge A Gutiérrez; Sandra A Rempel
Journal:  Neuro Oncol       Date:  2010-05-14       Impact factor: 12.300

4.  PTEN is a protein tyrosine phosphatase for IRS1.

Authors:  Yuji Shi; Junru Wang; Sarat Chandarlapaty; Justin Cross; Craig Thompson; Neal Rosen; Xuejun Jiang
Journal:  Nat Struct Mol Biol       Date:  2014-05-11       Impact factor: 15.369

5.  MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.

Authors:  Yu Ren; Xuan Zhou; Mei Mei; Xu-Bo Yuan; Lei Han; Guang-Xiu Wang; Zhi-Fan Jia; Peng Xu; Pei-Yu Pu; Chun-Sheng Kang
Journal:  BMC Cancer       Date:  2010-01-31       Impact factor: 4.430

6.  Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.

Authors:  Pei Yang; Yongzhi Wang; Xiaoxia Peng; Gan You; Wei Zhang; Wei Yan; Zhaoshi Bao; Yinyan Wang; Xiaoguang Qiu; Tao Jiang
Journal:  J Neurooncol       Date:  2013-03-13       Impact factor: 4.130

7.  Identification of nucleolus-localized PTEN and its function in regulating ribosome biogenesis.

Authors:  Pingdong Li; Danni Wang; Haiyang Li; Zhenkun Yu; Xiaohong Chen; Jugao Fang
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

8.  PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt.

Authors:  Jee-Yin Ahn; Yuanxin Hu; Todd G Kroll; Paulette Allard; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

9.  Glioblastoma Multiforme Oncogenomics and Signaling Pathways.

Authors:  Okezie O Kanu; Betsy Hughes; Chunhui Di; Ningjing Lin; Jinrong Fu; Darell D Bigner; Hai Yan; Cory Adamson
Journal:  Clin Med Oncol       Date:  2009-04-08

10.  A novel germline mutation of PTEN associated with brain tumours of multiple lineages.

Authors:  F J T Staal; R B van der Luijt; M R M Baert; J van Drunen; H van Bakel; E Peters; I de Valk; H K P van Amstel; M J B Taphoorn; G H Jansen; C W M van Veelen; B Burgering; G E J Staal
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.